- Home
- SYRE vs CRTO Comparison
SYRE vs CRTO Comparison
Compare SYRE & CRTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYRE
- CRTO
- Stock Information
- Founded
- SYRE 2013
- CRTO 2005
- Country
- SYRE United States
- CRTO France
- Employees
- SYRE N/A
- CRTO N/A
- Industry
- SYRE Biotechnology: Pharmaceutical Preparations
- CRTO Advertising
- Sector
- SYRE Health Care
- CRTO Consumer Discretionary
- Exchange
- SYRE Nasdaq
- CRTO Nasdaq
- Market Cap
- SYRE 1.1B
- CRTO 1.1B
- IPO Year
- SYRE 2016
- CRTO 2013
- Fundamental
- Price
- SYRE $23.56
- CRTO $20.52
- Analyst Decision
- SYRE Strong Buy
- CRTO Buy
- Analyst Count
- SYRE 6
- CRTO 9
- Target Price
- SYRE $57.60
- CRTO $39.11
- AVG Volume (30 Days)
- SYRE 1.3M
- CRTO 390.0K
- Earning Date
- SYRE 11-06-2025
- CRTO 10-29-2025
- Dividend Yield
- SYRE N/A
- CRTO N/A
- EPS Growth
- SYRE N/A
- CRTO 44.35
- EPS
- SYRE N/A
- CRTO 2.38
- Revenue
- SYRE N/A
- CRTO $1,946,032,000.00
- Revenue This Year
- SYRE N/A
- CRTO N/A
- Revenue Next Year
- SYRE N/A
- CRTO $1.84
- P/E Ratio
- SYRE N/A
- CRTO $8.62
- Revenue Growth
- SYRE N/A
- CRTO N/A
- 52 Week Low
- SYRE $10.91
- CRTO $19.50
- 52 Week High
- SYRE $40.26
- CRTO $47.27
- Technical
- Relative Strength Index (RSI)
- SYRE 70.08
- CRTO 43.65
- Support Level
- SYRE $21.88
- CRTO $20.26
- Resistance Level
- SYRE $24.02
- CRTO $21.00
- Average True Range (ATR)
- SYRE 1.62
- CRTO 0.66
- MACD
- SYRE 0.32
- CRTO 0.11
- Stochastic Oscillator
- SYRE 93.11
- CRTO 50.57
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
About CRTO Criteo S.A.
Criteo SA is an ad-tech company in the digital advertising market. Its technology, allows retailer advertisers to launch multichannel and cross-device marketing campaigns in real time. With real-time return on investment analysis of the ads, the firm's clients can adjust their marketing strategies dynamically. It has two reportable segments: Retail Media and Performance Media. The firm also provides technology allowing retailers to effectively manage their ad inventories and improve yield optimization.